|
|
|
|
|
|
|
|
If
you dont have an Acrobat Reader installed on your computer, you
may download it for free from the link below:
|
|
|
|
|
A Descriptive Study of Individuals with Membranoproliferative Glomerulonephritis
(Vol
34/No. 3. On-line test expires: 06/20/2009)
|
To
receive continuing education credit, you must read the
information in this article and take an on-line post
test and fill out an on-line program evaluation form.
The certificate will then be generated for you as a
.pdf file which you can print out locally on your computer.
CE Certification by ANNA requires a handling charge
that must be paid by credit card. Pricing information
is available by clicking on the "Post-Test Evaluation"
link below.
|
|
|
|
Please
download and print the PDF file below:
|
|
|
|
Der-Fa Lu, PhD, RN
|
Der-Fa Lu, PhD, RN, is Assistant Professor,
University of Iowa College of Nursing, Iowa City,
IA. For more information about this article, contact
her at der-fa-lu@uiowa.edu.
|
|
Ann Marie McCarthy, PhD, RN, FAAN
|
Ann Marie McCarthy, PhD, RN, FAAN, is
Professor and Chair, Parent-Child-Family Area,
University of Iowa College of Nursing, Iowa City,
IA.
|
|
Lynne D. Lanning, BSN, RN, JD
|
Lynne D. Lanning, BSN, RN, JD, is President,
Board of Advisors, Kidneeds, Iowa City, IA.
|
|
Connie Delaney, PhD, RN, FAAN
|
Connie Delaney, PhD, RN, FAAN, is Professor
and Dean, University of Minnesota School of
Nursing, Minneapolis, MN.
|
|
Craig Porter, MD
|
Craig Porter, MD, is Clinical Professor of
Pediatrics, University of Iowa College of Medicine,
Iowa City, IA.
|
Objective: Membranoproliferative Glomerulonephritis (MPGN) is one of a group of glomerulonephritides
that often begins in childhood and progresses to renal failure. The purpose of
this paper is to describe the initial results of a patient-driven database on individuals with
MPGN.
Sample/setting: Patients with MPGN Types I, II, and III and their family members were
recruited to this survey study.
Design: A population survey design was used.
Methods: A survey was developed for this study that obtained information from the individual
with MPGN or a guardian on: patient information, family/patient health history, history
of MPGN, medications, course of MPGN, history of dialysis, and history of transplant.
Surveys were completed either on-line or in paper format.
Results: Fifty-nine individuals who are primarily white (80%) and female (61%) with
MPGN Type II (52%) participated in this study. The average age of onset of MPGN in this
sample was 12 years. Ten (71%) of the total 14 patients with onset of less than 10 years of age
were female. Among these 10 female, 8 (80%) were diagnosed with MPGN II and developed
end stage renal disease.
Conclusion: Health screenings for blood pressure, urinary dipstick for both proteinuria and
hematuria play important roles in early detection for MPGN. Nurses must provide emotional
and information support to this population.
|
CE
RELATED INFORMATION |
|
This
offering for 1.5 contact
hours is being provided by
the
American
Nephrology Nurses’ Association
(ANNA), which
is accredited as a provider
and approver of continuing
education in nursing by
the American Nurses’
Credentialing Center-Commission
on Accreditation (ANCCCOA).
This educational activity
is approved by most states
and specialty organizations
that recognize the ANCC-COA
accreditation process. ANNA
is an approved provider of
continuing education in nursing
by the California Board of
Registered Nursing, BRN Provider
No. 00910; and the Kansas
State Board of Nursing, Provider
No. LT0148-0738. This offering
is accepted for RN and LPN
relicensure in Kansas
|
|
Goal:
Discuss the results of a patient-driven database on individuals with membranoproliferative glomerulonephritis (MPGN).
Objectives:
1. Discuss incidence, diagnosis, and etiology of MPGN.
2. List symptoms identified in the study that prompted patients to seek medical attention.
3. Identify health screenings in the pediatric population that are important in early detection of MPGN.
|
AUTHOR DISCLOSURE
STATEMENT |
Der-Fa Lu
has no conflicts of interest to disclose.
Ann Marie McCarthy
has no conflicts of interest to disclose.
Lynne D. Lanning
has no conflicts of interest to disclose.
Connie Delaney
has no conflicts of interest to disclose.
Craig Porter
has no conflicts of interest to disclose.
|
ANNA and HDCN CE POLICY STATEMENTS |
The CE policy and disclosure statements of the American Nephrology
Nurses' Association are given in detail on the Symposium
Home Page. The CE policy statements of HDCN are listed on
this page. |
|
|
|
| |
